Patents by Inventor Hongwei Ouyang

Hongwei Ouyang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240172984
    Abstract: The present disclosure discloses an electroencephalogram (EEG) emotion recognition method based on a spiking convolutional neural network. In the present disclosure, after EEG emotion data is preprocessed, a differential entropy feature is extracted and a time window is intercepted, and then a spiking convolutional encoder is configured to encode the EEG emotion data; a spiking convolutional feature extractor extracts a spiking data feature; and a spiking fully connected classifier performs learning and classification. In the present disclosure, a spiking neural network combining a spiking convolutional layer and a spiking fully connected layer is trained directly to achieve an objective of EEG emotion classification.
    Type: Application
    Filed: November 16, 2023
    Publication date: May 30, 2024
    Applicant: Hangzhou Dianzi University
    Inventors: Hong ZENG, Shuping LE, Feifan XU, Deng PAN, Haohao ZHENG, Yu OUYANG, Zhe JIA, Hongwei WANG
  • Publication number: 20230117670
    Abstract: The invention provides a bioactive substance composition, a serum-free medium comprising the composition and the uses thereof. The bioactive substance composition is used for serum-free medium and/or composition and the preparation thereof; The serum-free medium and/or composition can be used for primary culture and secondary culture of cells and/or tissues. The cells are selected from any one or more of tendon and/or ligament derived cells, chondrocytes, meniscus stem cells, mesenchymal stem cells, skeleton stem cells, and muscle stem cells. The tissue is the musculoskeletal system tissue. The bioactive substance composition and/or serum-free medium and/or the composition can be used to prepare drugs for tissue and/or organ injury treatment; The tissue or organ injury is selected from the tissue or organ injury of the musculoskeletal system.
    Type: Application
    Filed: December 14, 2022
    Publication date: April 20, 2023
    Inventors: Xiao CHEN, Hong ZHANG, Hongwei OUYANG, Zi YIN, Weiliang SHEN
  • Publication number: 20220324163
    Abstract: An integrally-formed three-dimensional (3D) bio-printing system capable of alternate feeding of multiple materials, comprising: an optical imaging unit and a light path conversion unit, wherein the optical imaging unit comprises an image processing unit and a projection unit, the image processing unit segmenting a 3D modeling graphic of a printed subject to form image information, the projection unit converting the image information into one or more optical images, and the light path conversion unit projects the imaged light paths into bio-ink that can be cured by light, so that the projected image can cure the bio-ink by means of the focus of light.
    Type: Application
    Filed: July 24, 2019
    Publication date: October 13, 2022
    Inventors: Hongwei OUYANG, Renjie LIANG, Yi HONG, Shufang ZHANG, Oikai LI, Yiwei ZOU, Feifei ZHOU
  • Patent number: 11446409
    Abstract: The purpose of the present invention is to provide a light control agent and explore its application, and is expected to improve the tissue binding force and convenience of the existing biological glue material by providing a new reagent or material for biological damage or homeostasis. In one of embodiment, this invention provides an agent for repairing biological damage or homeostasis, wherein the agent comprises a natural biological macromolecule modified by the photo-responsive cross-linking group.
    Type: Grant
    Filed: March 11, 2020
    Date of Patent: September 20, 2022
    Assignee: HAINING ZHULUOJI BIOTECHNOLOGY CO., LTD.
    Inventors: Hongwei Ouyang, Yi Hong, Feifei Zhou, Shufang Zhang
  • Patent number: 11311649
    Abstract: The present invention relates to the technical field of silk scaffolds, and in particular, to a silk/pet mix-woven scaffold and a preparation method and use thereof. The silk/PET mix-woven scaffold is formed by weaving silk and PET fibers. Sericin of the silk is removed. The silk and the PET fibers are mixed and knitted. The PET fibers provide reliable fixation in an early stage to maintain the stability of mechanical properties, and the silk degrades gradually in a later stage to promote the growth of new tissues to achieve the integration of the scaffold and the body. When the scaffold is used for artificial tendon/ligament recovery, its overall performance is better than that of pure silk or pure PET fiber scaffolds, and the scaffold has excellent clinical transformation potential.
    Type: Grant
    Filed: June 12, 2020
    Date of Patent: April 26, 2022
    Assignee: ZHEJIANG UNIVERSITY
    Inventors: Weiliang Shen, Hongwei Ouyang, Xiao Chen, Jiayun Huang
  • Publication number: 20210178018
    Abstract: The present invention relates to the technical field of silk scaffolds, and in particular, to a silk/pet mix-woven scaffold and a preparation method and use thereof. The silk/PET mix-woven scaffold is formed by weaving silk and PET fibers. Sericin of the silk is removed. The silk and the PET fibers are mixed and knitted. The PET fibers provide reliable fixation in an early stage to maintain the stability of mechanical properties, and the silk degrades gradually in a later stage to promote the growth of new tissues to achieve the integration of the scaffold and the body. When the scaffold is used for artificial tendon/ligament recovery, its overall performance is better than that of pure silk or pure PET fiber scaffolds, and the scaffold has excellent clinical transformation potential.
    Type: Application
    Filed: June 12, 2020
    Publication date: June 17, 2021
    Inventors: Weiliang SHEN, Hongwei OUYANG, Xiao CHEN, Jiayun HUANG
  • Publication number: 20200206383
    Abstract: The purpose of the present invention is to provide a light control agent and explore its application, and is expected to improve the tissue binding force and convenience of the existing biological glue material by providing a new reagent or material for biological damage or homeostasis. In one of embodiment, this invention provides an agent for repairing biological damage or homeostasis, wherein the agent comprises a natural biological macromolecule modified by the photo-responsive cross-linking group.
    Type: Application
    Filed: March 11, 2020
    Publication date: July 2, 2020
    Inventors: Hongwei Ouyang, Yi Hong, Feifei Zhou, Shufang Zhang